| Particulars |
| Company Name |
Cohance Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
38.26 |
| B.V. Rs |
115.30 |
| Sales Rs in Cr. |
1,093.51 |
| NP Rs in Cr. |
271.77 |
| NP Var% |
-8.00 |
| Div% |
0.00 |
| CPS Rs |
8.60 |
| EPS Rs |
7.10 |
| Traded Value(Rs in Lakhs) |
1,940.12 |
| 52 Week High |
1,328.00 |
| 52 Week Low |
304.00 |
| Price BSE |
308.00 |
| Price NSE |
309.00 |
| Market Capital(Rs in Cr.) |
11,771.59 |
| P/C Ratio |
35.80 |
| P/E Ratio |
43.40 |
| Price Vs.BV |
2.67 |
| Latest Quarter |
| Year End |
202512 |
| Sales Rs in Cr. |
481.58 |
| NP Rs in Cr. |
50.80 |
| NP Var % |
-67.00 |
| Trailing Twelve Months |
| Year End |
202512 |
| Sales |
914.50 |
| OPM |
38.71 |
| NP |
247.20 |
| NP Var% |
-19.81 |
| EPS |
8.84 |
| PE |
34.81 |
|